In today's fast-paced world, where time and accuracy are of the essence, point-of-care testing (POCT) platforms have become an indispensable tool in the field of diagnostics. POCT platforms enable healthcare professionals to conduct rapid and accurate tests, without the need for lab facilities. This not only saves time but also makes medical care more accessible and affordable to people in remote areas.
Prometheus is a leading name in the world of POCT platforms, offering state-of-the-art technology that delivers reliable and accurate test results. Here's a closer look at the three POCT platforms offered by Prometheus.
This platform is based on the principle of immunochromatography, where samples move along a strip coated with antibodies. Over time, a color change indicates the presence or absence of the target substance. The Colloidal Gold Platform is widely used for testing pregnancy, drugs of abuse, infectious diseases, and more.
This platform uses antibodies that bind to the target substance and then emit light when excited by an external source. Immunofluorescence is particularly useful for detecting viral and bacterial infections, autoimmune disorders, and cancer markers.
This platform integrates state-of-the-art technology, such as microfluidics, sensing techniques, and artificial intelligence, to deliver rapid and accurate diagnostic tests. It is ideal for rapid diagnosis and monitoring of infectious diseases, metabolic disorders, and cardiovascular diseases.
As top of leading point of care testing manufacturers, Prometheus, we are committed to pushing the frontiers of diagnostic testing with our point of care testing products. Our cutting-edge technology, together with our excellent customer support, makes us the ideal partner for healthcare providers worldwide. Join us in our mission to revolutionize diagnostic testing!